A clinically studied botanical complex combining Bergamonte® citrus bergamot and Adapticort® Eurycoma longifolia to support healthy weight management through complementary metabolic and stress-adaptation pathways in a non-stimulant formulation.
Weight management is rarely driven by one physiological factor. CitruSlim® was developed around two areas that can influence the weight-management journey: metabolic function and the physiological response to stress. By bringing standardized Bergamonte® and Adapticort® together in one clinically evaluated formulation, CitruSlim® offers a distinctly different platform from conventional stimulant or thermogenic approaches.
CitruSlim® was directly evaluated as a finished formulation in a 112-day exploratory, randomized, double-blind, placebo-controlled human study. Researchers compared 600 mg/day and 1,200 mg/day with placebo under the same diet and activity program, with both CitruSlim® groups demonstrating significant BMI reductions versus placebo. The finished-formula research is complemented by separate human studies supporting the metabolic and stress-adaptation rationale behind its Bergamonte® and Adapticort® components.
In a 112-day randomized, double-blind, placebo-controlled study, both clinically studied CitruSlim® intakes produced significant reductions in BMI.
BMI decreased by approximately 3.2% at 600 mg/day and 3.3% at 1,200 mg/day, while the placebo group showed a nonsignificant increase. Both CitruSlim® groups differed significantly from placebo at p < 0.001.
Why it matters: The finished CitruSlim® combination has direct placebo-controlled human evidence for healthy weight positioning.
The lower CitruSlim® intake delivered nearly the same BMI response as twice the daily amount. After 112 days, BMI decreased approximately 3.2% at 600 mg/day versus 3.3% at 1,200 mg/day, with both groups significantly different from placebo.
Why it matters: A clinically studied 600 mg/day intake leaves more room for complementary ingredients in multi-ingredient weight-management formulas.
CitruSlim® brings together two botanical platforms with different research backgrounds. Bergamonte® has been studied in relation to weight and metabolic markers, while standardized Eurycoma longifolia has separate human research examining cortisol and the physiological stress response.
CitruSlim® then evaluated the finished combination directly, demonstrating significant BMI reduction versus placebo at both clinically studied intakes.
Why it matters: The formula combines complementary research backgrounds with direct clinical testing of the finished CitruSlim® ingredient.
Study note: The CitruSlim® trial was an exploratory 112-day randomized, double-blind, placebo-controlled study in overweight and obese adults. All groups followed the same calorie-controlled diet and light-activity program. The strongest placebo-controlled findings were for BMI/body-weight management; significant between-group effects were not demonstrated for body-fat percentage or the lipid profile. Findings should be interpreted in the context of the studied formulation, doses, population and lifestyle protocol.
Hancke J, Srivastava S, Caceres DD, Burgos RA, Alarcon P. An exploratory double-blind, randomized, placebo-controlled study to assess the efficacy of CitruSlim on body composition and lipid parameters in obese individuals. Phytotherapy Research. 2021;35(12):7039–7049. doi:10.1002/ptr.7331.
CitruSlim® combines a direct clinical weight-management story with complementary botanical support for metabolic function and stress adaptation, creating a platform designed around the realities of long-term weight management.
CitruSlim® moves beyond combining separately researched ingredients by putting the finished botanical system itself into a randomized, placebo-controlled human study.
CitruSlim® is positioned as a clinically studied, non-stimulant botanical for healthy weight management, with BMI providing the clearest direct clinical endpoint. Its differentiation comes from approaching weight through complementary metabolic and stress-adaptation systems rather than relying on thermogenesis or appetite suppression. This makes CitruSlim® particularly relevant to daily-use weight-management products designed around a more sustainable wellness story, with metabolic health and healthy stress response adding depth while healthy weight remains the primary clinical position.
CitruSlim® is a proprietary botanical combination of Bergamonte® citrus bergamot and Adapticort® Eurycoma longifolia. The clinical formulation was developed specifically for healthy weight management, metabolic support and stress adaptation.
Yes. The finished CitruSlim® combination was evaluated in a 112-day randomized, double-blind, placebo-controlled human trial. Both 600 mg/day and 1,200 mg/day produced significant reductions in BMI compared with placebo.
The combination brings together two complementary research areas. Bergamonte® provides the metabolic component, while Adapticort® provides an adaptogenic component relevant to physiological stress and cortisol response. CitruSlim® combines both within one clinically evaluated ingredient.
CitruSlim® is built around metabolic support and stress adaptation rather than thermogenic stimulation. This makes it relevant to non-stimulant weight-management concepts designed for ongoing daily use.
let’s get started
Discuss your formulation goals, intended positioning, research needs, and product-development opportunities with the HP Ingredients team.
Schedule Now
Evaluate Bergamonte® for your next product concept with a sample for formulation, compatibility, and product-development testing.
Request Now
Ready to explore how Bergamonte® can support your product pipeline? Contact HP Ingredients for samples, technical documentation, clinical research, formulation guidance, and next-step support.
Contact Us
